Erschienen in:
22.07.2023 | Editorial
Collection on molecular imaging in neurodegeneration
verfasst von:
Fang Xie, Ruiqing Ni
Erschienen in:
European Journal of Nuclear Medicine and Molecular Imaging
|
Ausgabe 11/2023
Einloggen, um Zugang zu erhalten
Excerpt
The prevalence and incidence of neurogenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) are rapidly increasing with the aging society [
1,
2]. Clinical assessment and traditional FDG imaging offer limited accuracy in the early and differential diagnosis of neurodegenerative diseases. Molecular imaging, including positron emission tomography (PET) and single photon emission computed tomography (SPECT), along with functional and structural imaging by magnetic resonance imaging, provides precision approaches to facilitate the diagnosis of neurogenerative diseases [
3‐
5]. …